ERBB2 and triple-negative breast carcinoma: Compared to normal tissues in BRCA tumors, the expression of UBE2C was higher in all different subtypes, including triple negative breast cancer (TNBC), HER2-amplification, and luminal subtype (Table 1 and Figure S2 panel 2A).